SENIOR DIRECTOR MEDICAL ONCOLOGY at Fortis Gurgaon
EXPERTISE: Medical Oncology
QUALIFICATION: MBBS, MD - Medicine, DM - Medical Oncology.
PRACTICING AT: Fortis Memorial Research Institute
TRAINED AT: Maulana Azad Medical College
PUBLICATIONS: Innumerable Publications in International and National Journal / Books of repute. Lead Author of largest real world Indian data on Targeted therapy (Cetuximab )in head and neck cancer, Acute Myeloid leukemia treatment, Human Papilloma Virus trends in Indian Population etc. Lead founder of various innovative oncology educational platforms and networks (International and national) : Evidence based debates in oncology, Live oncology tumor boards , Master classes and workshops in oncology. Advisors to various Biopharmaceutical Research & Development Professional Guides to various international and national Medical oncology fellows and students. Lead various NGO’s for "No Tobacco" workshop for teens in Delhi Schools
REGISTRATION: 1854 Delhi Medical Council, 2004
EDUCATION:
MBBS, MD - Medicine, DM - Medical Oncology.
ANY SUCCESS STORY:
Awards and Recognitions
Gold Medal for best outgoing post graduate student (Internal Medicine), Delhi University - 2007
Multiple publications in various international and national journals.
Memberships
American Society of Clinical Oncology (ASCO)
European Society of Medical Oncology (ESMO)
Indian Society of Medical and Paediatric Oncology (ISMPO)
DESCRIPTION: Dr. Ankur Bahl is a highly skilled cancer specialist who has more than 15+ years of rich experience in this field. He is an alumni of Maulana Azad Medical College Delhi from where he did his MBBS, followed by MD Medicine. He has done his DM Medical Oncology from the prestigious AIIMS New Delhi. He has also completed course on Adverse Drug Reactions, Drug Interactions and Pharma covigilance at the University of Oxford UK. Dr. Bahl holds clinical expertise in Immunotherapy, targeted therapies in combination with Chemotherapy, Hormonal Therapy, Supportive and Palliative Care. He is the lead author of largest real world Indian data on targeted therapy(Cetuxmab) in Head & Neck cancer, Acute Myeloid Leukemia Treatment, Human Papilloma Virus trends in Indian Population etc. He is also the lead founder of various innovative oncology educational platforms and networks(International and national) Evidence based debates in oncology, Live Oncology Tumor boards, Master Classes and workshops in oncology Dr Bahl has joined FMRI, Gurugram from Max Hospital, Saket where he was Director- Medical Oncology and Hematology Oncology, Previously he was associated with prestigious organization like Rajiv Gandhi Cancer Institute and Research Centre and Maulana Azad Medical College.
